MiniMed Group, Inc.

MMED Healthcare Medical Instruments & Supplies

MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.

18.23 1.06 −5.50%
Market cap
$5.1B
P/E
0.0×
Fwd P/E
27.8×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−3.09
Dividend safety
n/a

MiniMed Group, Inc. (MMED) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, MiniMed Group, Inc. (MMED) trades at a EV/Sales of 1.6×. Over the past ten years it has ranged from 0.0× (July 2026) to 2.1× (September 2026); the current reading is higher than 64% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 0.0× —
FY2025 0.0× —
FY2024 0.0× —

Quarterly newest first

Period EV/Sales Change
Jul 2026 1.6× —
Jan 2026 0.0× —
Jul 2025 0.0× —
Jan 2025 0.0× —

Against its own ten years

Low 0.0× High 2.1×
Ten-year median 0.0×
Current reading's percentile 64

EV/Sales against peers

Company EV/Sales
NVST Envista Holdings Corporation compare 1.5×
MMED MiniMed Group, Inc. 1.6×
BLCO Bausch + Lomb Corporation compare 2.2×
ICUI ICU Medical, Inc. compare 2.3×
STVN Stevanato Group S.p.A. compare 2.8×
MMSI Merit Medical Systems, Inc. compare 3.5×
TFX Teleflex Incorporated compare 4.1×
ATRC AtriCure, Inc. compare 4.9×
PLSE Pulse Biosciences, Inc compare 2,578×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MMED